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Aleutian mink disease parvovirus (ADV) is distinct among the parvoviruses as infection in vivo is persistent, restricted, and
noncytopathic. In contrast, infections with other more prototypic parvoviruses, like mink enteritis virus (MEV), are acute,
cytopathic, and characterized by permissive replication in vivo. Although apoptosis results in the death of cells acutely
infected by parvoviruses, the role of apoptosis in ADV infections is unknown. Permissive infection of ADV resulted in
apoptosis of Crandell feline kidney (CrFK) cells as indicated by TUNEL staining, Annexin-V staining, and characteristic
changes in cell morphology. Pretreatment of infected cells with caspase 3 or broad-spectrum caspase inhibitors prevented
apoptosis. In addition, treatment of infected cells with these inhibitors caused a 2 log10 reduction in the yield of infectious
virus compared to untreated cultures. This block in replication preceded substantial viral DNA amplification and gene
expression. However, inhibitors of caspases 1, 6, and 8 did not have this effect. MEV also induced caspase-dependent
apoptosis following infection of CrFK cells, although production of infectious progeny was not affected by inhibition of
apoptosis. Thus, permissive replication of ADV in vitro depended upon activation of specific caspases. If ADV infection of
cells in vivo fails to initiate caspase activation, the requirement of caspase activity for replication may not be met, thus
providing a possible mechanism for persistent, restricted infection. © 2002 Elsevier ScienceKey Words: parvovirus; Aleutian mink disease parvovirus; caspase; apoptosis; persistent infection; replication; mink; mink
enteritis virus; TUNEL.INTRODUCTION
At the level of a single cell, infection with Aleutian mink
disease parvovirus (ADV) is complex as it exhibits two
distinct patterns of virus replication. ADV can initiate a
cytopathic, permissive infection in CrFK (Crandell feline
kidney) cells in vitro and in type II pneumocytes in new-
born mink kits (Alexandersen and Bloom, 1987; Alex-
andersen et al., 1986). This infection is characterized by
high levels of viral DNA replication, RNA transcription,
and translation and the production of infectious progeny
virus. However, the picture is very different during per-
sistent infection of adult mink. In this case, the main
target cells for virus infection are lymph node macro-
phages, and replication at the level of the individual cell
is restricted (Alexandersen et al., 1988; Kanno et al.,
1992). The restricted replication is noncytopathic, and
viral DNA replication, RNA transcription, protein expres-
sion, and production of progeny occur at low levels.
The observations in ADV replication are in contrast to
other parvoviruses in immunocompetent hosts, such as
H-1 of rats, minute virus of mice (MVM), and B19 of
humans. These viruses replicate rapidly in cells such as
intestinal epithelial cells, hematopoietic stem cells, ery-1 To whom correspondence and reprint requests should be ad-
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224throid precursors, and lymphoid cells (Bueren et al., 1991;
Ikeda et al., 1998; Morey et al., 1993; Segovia et al., 1995,
1991, 1999). During infection, cell death occurs in these
target cell populations and leads to the acute clini-
cal manifestations of gastroenteritis, aplastic anemia,
and lymphopenia. This cell death is a consequence of
apoptosis (Ikeda et al., 1998; Morey et al., 1993; Rayet
et al., 1998). However, although permissive ADV replica-
tion is cytopathic, it is not known if apoptosis occurs in
the infected cells.
Apoptosis or programmed cell death is a tightly regu-
lated, physiological process involved in normal cell turn-
over and is characterized by distinct morphological
changes and DNA degradation (Kerr et al., 1972).
Caspases or cysteine proteases are central to the induc-
tion of apoptosis (Wolf and Green, 1999). Caspase acti-
vation involves a complex proteolytic cascade in which
inactive proenzymes or zymogens are cleaved to gener-
ate the active enzymes. The zymogens with a longer
prodomain are activated first and thus are called initiator
caspases. These include caspases 8, 9, and 10, which
may be activated through a number of stimuli, including
ligation of the cell surface receptors for FAS or TNFa,
oxidative stress, UV irradiation, or serum deprivation
(Roy and Nicholson, 2000). Initiator caspases then acti-
vate zymogens with a shorter prodomain called execu-
tioner caspases. The executioner caspases, including
CrFK c
optotic
225ADV REPLICATION DEPENDS ON CASPASE ACTIVITYcaspases 3, 6, and 7, next cleave and/or activate a host
of cytoskeletal, cytosolic, and nucleosomal proteins re-
quired for the stepwise dismantling of the cell during cell
death (reviewed in Saikumar et al., 1999; Vaux, 1999; Wolf
and Green, 1999). Because this process has the obvious
potential to disrupt virus replication, numerous viruses
(e.g., herpes simplex virus, Epstein–Barr virus, and pox-
viruses) have adapted strategies to evade apoptosis
(Everett and McFadden, 1999; Hardwick, 1998; Hender-
son et al., 1993; Rao et al., 1997).
The use of peptide inhibitors of specific caspases has
made it possible to identify caspases activated in cells
following virus infection. Apoptosis following in vitro in-
fection with H-1 or MVM parvoviruses depends on the
activation of caspases 3 (Ohshima et al., 1998), 6, and 8
(Rayet et al., 1998). Furthermore, the main nonstructural
protein (NS1) of MVM and B19 causes apoptosis follow-
ing induced expression in certain transformed cell cul-
tures or following natural infection, respectively (Caillet-
Fauquet et al., 1990; Mousset et al., 1994; Rayet et al.,
1998). This NS1-induced apoptosis is also dependent on
FIG. 1. TUNEL and anti-ADV staining of ADV-infected CrFK cells at 7
for TUNEL (green) and NS1 (red). (B) ADV-infected CrFK cells stained
(yellow). (C) NS1 staining (red) of apoptotic cells (green) showing the r
TUNEL (green), NS1 (blue), and capsid (red) proteins. (E) ADV-infected
fragmented nucleus and membrane blebbing and that in E depicts apactivation of caspases 3, 6, and 8 (Moffatt et al., 1998;
Rayet et al., 1998; Sol et al., 1999).In the present study, we have determined that ADV
induces apoptosis during permissive replication in CrFK
cells in vitro, similar to other models of parvovirus infec-
tion. Using specific caspase inhibitors, ADV-induced
apoptosis was shown to be dependent on the activation
of specific caspases. The inhibition of these caspases
and the subsequent inhibition of apoptosis reduced ADV
replication by 100-fold compared to uninhibited cultures.
Although infection of CrFK cells with another parvovirus
of mink, mink enteritis virus (MEV), also induced apopto-
sis, the production of infectious MEV progeny was not
affected by caspase inhibition. The dependence of ADV
replication on caspase activity is therefore potentially
unique among the parvoviruses.
RESULTS
Permissive replication of ADV in vitro causes
apoptosis
To determine if ADV causes apoptosis during permis-
sive infection, synchronized CrFK cells were infected
A) CrFK cells treated with UV-inactivated ADV-G at 72 hpi and stained
EL (green) and NS1 (red) showing many ADV-infected apoptotic cells
NS1 protein in the cell nucleus. (D) ADV-infected CrFK cell stained for
ell stained for TUNEL (green) and NS1 (red). The image in D shows a
bodies (arrows), all characteristics of cellular apoptosis.2 hpi. (
for TUN
ing ofwith ADV-G or UV-inactivated ADV-G. At the specified
times, samples of cells were cytocentrifuged and stained
226 BEST, WOLFINBARGER, AND BLOOMto correlate ADV infection and apoptosis (Fig. 1). In this
set of studies, DNA is labeled by terminal dUTP nick end
labeling (TUNEL) in green and ADV NS1 is red; colocal-
ization of NS1 and TUNEL is yellow. In triple-color la-
beled cytospins (Fig. 1D), DNA is labeled by TUNEL in
green, ADV NS1 is blue, and ADV capsid protein is red.
Cells treated with UV-inactivated ADV-G (control cul-
tures) exhibited only a small number of TUNEL-positive
cells over a 72-h incubation period, establishing the
background levels (Fig. 1A). Clear evidence of ADV in-
fection and apoptosis was observed in infected cultures
as early as 9 hpi and the level increased throughout the
culture period (Figs. 1B and 1C). Many TUNEL-positive
cells had the characteristic morphology of apoptotic
cells, appearing shrunken with blebbed membranes
(Fig. 1D) and often containing apoptotic bodies (Fig. 1E,
arrows).
By 72 hpi with ADV, greater than 90% of ADV-infected
cells were also positive for TUNEL while cells that did
not express virus antigen were typically TUNEL negative
and did not appear apoptotic. This indicated that ADV
infection did not induce apoptosis in adjacent, unin-
fected cells. The level of TUNEL-positive cells in cultures
incubated with UV-inactivated ADV was the same as in
untreated cells, indicating that the induction of pro-
grammed cell death by ADV was associated with virus
replication and was not simply due to virus particles
binding to the cell surface and initiating apoptosis.
The single-stranded DNA ADV genome is converted to
a variety of duplex forms during genome amplification
and replication. Consequently, free 39 ends of viral DNA
might be present as transient replicative intermediates,
and the TUNEL reaction might inadvertently label these
FIG. 2. Annexin-V labeling of ADV-infected CrFK cells. Cells infected
with ADV, mock-infected, or treated with UV-inactivated ADV were
labeled with Annexin-V and counted by flow cytometry. Error bars
represent the standard error between three independent cultures.structures and mark virus-infected cells not actually un-
dergoing apoptosis (Morey et al., 1993). Therefore, wealso employed an alternate method for detecting pro-
grammed cell death, specifically Annexin-V staining, an
early indicator of apoptosis induction. In ADV-G-infected
cells, the number of cells positive for Annexin-V in-
creased from 0.6 6 0.4% at 0 hpi to 39.1 6 3.2% (mean 6
SE) at 72 hpi (Fig. 2). This was similar to the number of
cells that stained positive by TUNEL (see Fig. 3). In
contrast, uninfected cultures and cultures treated with
UV-inactivated virus showed only background levels of
staining for Annexin-V at 72 hpi (Fig. 2). These results
confirmed that infection with ADV is associated with
apoptosis of infected cells and that TUNEL labeling was
a suitable method for detecting apoptotic cells.
ADV-induced apoptosis is caspase dependent
A number of caspases involved in programmed cell
death have specific synthetic inhibitors capable of oper-
ating in cells (Table 1). These inhibitors were employed
to examine the role of specific caspases in ADV-induced
apoptosis. CrFK cells were pretreated for 24 h with the
caspase inhibitors and then infected with ADV. At various
time points after infection, cultures were sampled for the
presence of apoptosis by TUNEL and the percentage of
TUNEL-positive cells was determined by flow cytometry
(Fig. 3). At time zero, 0.68 6 0.31% of cells in all cultures
were TUNEL positive. The number of TUNEL-positive
cells was measured over 120 h of infection (data not
shown), with the maximum level observed at 72 hpi. At 72
hpi, cells from untreated ADV-infected cultures were
53.2 6 7.2% TUNEL positive. The number of apoptotic
cells was greatly reduced in ADV-G-infected cultures
treated with caspase 3 or broad-spectrum caspase in-
hibitors. In contrast, the levels of TUNEL-positive cells in
ADV-infected cultures treated with inhibitors of caspase
1, caspase 6 (not shown), and caspases 6 and 8 were not
markedly different from untreated cultures. These results
suggested that ADV-induced apoptosis is dependent on
the activation of specific caspases and that the activity of
caspase 3-like caspases in particular is important for
ADV-induced apoptosis.
We wished to determine whether inhibiting the activity
of a noncaspase protein involved in apoptosis could
TABLE 1
Synthetic Inhibitors and Their Target Proteins
Inhibitor Protein
YVAD-CHO Caspase 1
Ac-DEVD-CHO Caspase 3
Ac-VEID-CHO Caspase 6
Ac-IETD-CHO Caspases 6 and 8
z-VAD-FMK ICE-like caspases (caspases 1, 3, 5, 7, 8, 9)
Int-H1-S6A c-myc
Ac-FA-FMK Cathepsin B
227ADV REPLICATION DEPENDS ON CASPASE ACTIVITYprevent ADV-induced apoptosis. C-myc is a transcrip-
tional regulator activated late in apoptosis and is essen-
tial in some systems for the complete process of pro-
grammed cell death (Prendergast, 1999). In ADV-infected
CrFK cells, c-myc was indeed a pro-apoptotic factor,
because inhibition of the c-myc protein greatly reduced
the level of apoptosis (Fig. 3). However, a proportion of
the apoptosis still occurred, suggesting either that c-myc
protein function was not completely inhibited or that
more than one biochemical pathway was involved in
ADV-induced apoptosis. Nevertheless, these observa-
tions suggested that c-myc protein function is required
for maximal ADV-induced apoptosis.
Inhibition of specific caspases inhibits expression of
virus proteins and production of infectious virus
progeny
To examine the effects of inhibiting caspases and
c-myc on ADV replication, we first looked at expression
of viral proteins in infected cells. ADV-infected cultures in
which apoptosis was inhibited had reduced numbers of
ADV-positive cells. When ADV-G-infected cultures were
treated with the caspase 3 inhibitor or the broad-spec-
trum caspase inhibitor for 72 h, the number of cells
staining for NS1 and TUNEL was markedly reduced
compared to infected untreated cultures (Fig. 4). This
effect was more pronounced in cells treated with the
broad-spectrum inhibitor than those treated with
caspase 3 inhibitor. The number of cells that were NS1
and TUNEL positive did not appear to be different be-
FIG. 3. TUNEL-positive cells in ADV-infected CrFK cells treated with
caspase and c-myc inhibitors. CrFK cells were pretreated with inhibitor
for 24 h and infected with 10 FFU/cell ADV under continuous treatment
with the inhibitor. At various times after infection, cells were harvested,
labeled with TUNEL, and counted by flow cytometry (mean 6 SE for
three experiments).tween untreated cells and cells treated with inhibitors of
caspase 1, caspase 6, caspase 6/8, or c-myc (data notshown). Thus, inhibition of some caspases, and particu-
larly caspase 3-like caspases, reduced the numbers of
ADV-positive cells.
The output of infectious ADV progeny was also mea-
sured to determine if the reduction in the number of
ADV-positive cells reflected reduced virus production
(Fig. 5). Virus titer was examined over a 72-h time course.
This represents one cycle of virus replication as ADV
cannot infect cells following the initial round of replica-
tion and therefore does not spread between cells in
culture (Bloom et al., 1980; Storgaard et al., 1997). At time
zero, virus titers in all cultures ranged from 2.1 3 103 to
1.9 3 104 fluorescence-forming units (FFU)/ml. These
values represented the amount of virus bound to cells
following the initial hour of incubation. The observation
that there was no difference in virus titer at time zero
between treatments suggests that the addition of inhib-
itors to cultures did not block the attachment of the virus
to the cell surface. By 72 hpi (the time at which virus titer
was maximal), the range of virus titers from control cells
infected with ADV-G was 4.5 3 105 to 4.8 3 106 FFU/ml.
Treatment with caspase 3 inhibitor or broad-spectrum
inhibitor resulted in a marked decrease of virus titer to
approximately 2.1 3 104 and 6.0 3 103 FFU/ml at 72 hpi,
respectively, a reduction of approximately 2 log10 com-
pared to control cells. The ability of caspase 3 inhibitor or
broad-spectrum inhibitors to reduce the levels of infec-
tious virus was dose-dependent (data not shown). In
contrast, similar treatment of infected cultures with in-
hibitors of caspase 1, 6, and 8 and c-myc had no effect on
virus growth at 72 h. These results indicated that repli-
cation of ADV was dependent on the activity of particular
caspases and specifically caspase 3-like caspases. In
addition, virus replication was not directly inhibited by
treatment of cells with peptide inhibitors. The observa-
tion that inhibition of c-myc did not affect ADV progeny
production suggests that ADV replication is dependent
on specific factors activated during apoptosis and not
simply on the induction of apoptosis for aspects of the
virus life cycle such as efficient virus release.
Although the caspase inhibitors we employed are spe-
cific, it has been demonstrated that the cysteine pro-
tease cathepsin B can be blocked by the caspase inhib-
itors Ac-YVAD-CHO, Ac-DEVD-CHO, and z-VAD-FMK
(Schotte et al., 1999). Parvoviruses infect cells via endo-
cytosis into the lysosomes, and cathepsin B is a lysozy-
mal enzyme involved in the degradation of endocytosed
proteins. It was therefore important to determine if the
effect of the caspase inhibitors on virus titer was due to
inadvertent inhibition of cathepsin B. This control was
also required as commercial antibodies against human
or murine caspases were not cross-reactive with
caspases in the feline cell line in Western blots (data not
shown), making it difficult to demonstrate specific inhi-
bition of caspases. CrFK cells were pretreated with the
cathepsin B inhibitor Ac-FA-FMK and infected with ADV
d CrFK
228 BEST, WOLFINBARGER, AND BLOOMfor up to 72 h. Virus replication was then examined by IFA
and virus titration, and apoptosis was measured by
TUNEL. The number of ADV-positive cells and the virus
titer were very similar between Ac-FA-FMK-treated and
untreated cultures over the course of infection (Fig. 6A),
as was the level of TUNEL-positive cells (Fig. 6B). This
suggested that the reduced ADV titers observed in
caspase 3 inhibitor- or broad-spectrum inhibitor-treated
cultures were not due to inhibition of cathepsin B.
Mink enteritis virus replication is not dependent on
apoptosis of infected cells
We wished to determine if the dependence of ADV
replication on caspase activity was unique to ADV or was
a more general property of parvoviruses. In contrast to
ADV, MEV, another autonomous parvovirus of mink, rep-
licates permissively in its adult host. In addition, both
MEV and ADV replicate permissively in CrFK cells, en-
abling us to compare two distinct mink parvoviruses in
the same cell line. We first examined the effect of
caspase inhibition on MEV-induced apoptosis by TUNEL
labeling and flow cytometry (Fig. 7A). Similar to ADV-
infected CrFK cells, 48.5 6 6.7% of MEV-infected CrFK
cells were TUNEL positive at 72 hpi. Treatment of MEV-
infected cells with caspase 3 inhibitor, caspase 6/8 in-
hibitor, or the broad-spectrum caspase inhibitor all re-
duced the levels of TUNEL-positive cells over 72 h of
culture. However, treatment of cells with caspase 1 in-
hibitor had no effect on apoptosis compared to untreated
cultures. Thus, like ADV, MEV-induced apoptosis is de-
pendent on caspase activity. However, unlike for ADV,
activity of caspases 6 and/or 8 is important in MEV-
induced apoptosis.
At time zero, MEV titers in all cultures ranged from
3.9 3 103 to 1.1 3 104 FFU/ml (Fig. 7B). Treatment of cells
FIG. 4. TUNEL (green) and anti-NS-1 (red) staining of ADV-infected C
CrFK cells at 72 hpi. (B) Broad-spectrum caspase-inhibited ADV-infecte
hpi. Bars represent 40 mm.with caspase 3 inhibitor, caspase 6/8 inhibitor, or the
broad-spectrum caspase inhibitor did not alter thegrowth of MEV over 72 h compared to untreated cultures,
with titers from all cultures between 7.4 3 105 and 1.1 3
107 FFU/ml at 72 hpi. The slightly reduced virus titer at 72
hpi following treatment with caspase 6–8 inhibitor was
probably not due to the inhibitor as MEV titers in these
cultures were equivalent at 60 hpi to untreated cultures
at 72 hpi. These results indicated that inhibition of
caspases did not markedly affect the production of MEV
progeny.
Inhibition of caspases inhibits ADV DNA amplification
and gene expression
To examine the stage of virus replication blocked by
the caspase inhibitors, ADV viral DNA amplification and
gene expression were analyzed using Southern and
Western blotting, respectively (Fig. 8). Treatment of ADV-
infected CrFK cells with the broad-spectrum inhibitor of
lls treated with caspase inhibitors. (A) Control untreated ADV-infected
cells at 72 hpi. (C) Caspase 3-inhibited ADV-infected CrFK cells at 72
FIG. 5. Virus progeny production from ADV-infected CrFK cells
treated with caspase and c-myc protein inhibitors. CrFK cells were
pretreated with inhibitor for 24 h and infected with 10 FFU/cell ADVrFK ceunder continuous treatment with the inhibitor. At 0 and 72 hpi, cells
were harvested for virus titrations (mean 6 SE for three experiments).
229ADV REPLICATION DEPENDS ON CASPASE ACTIVITYcaspases consistently reduced the levels of ADV DNA
production detectable at 48 and 72 hpi compared to that
from untreated ADV-infected cultures (Fig. 8A). All the
DNA replicative intermediates (single-stranded, duplex
monomer, and duplex dimer DNA) were decreased, sug-
gesting a global decline in DNA replication, rather than
reduction of a particular intermediate.
Treatment of ADV-infected CrFK cells with the caspase
3 inhibitor reduced the levels of DNA intermediates at 48
hpi, although levels had recovered by 72 hpi. Levels of
ADV DNA in caspase 1- or caspase 6- and 8-inhibited
cultures were not different from untreated cultures over 4
days of infection. Virus DNA was not detected in cell
cultures treated with UV-inactivated ADV. These results
suggested that inhibition of caspases greatly restricted
viral DNA amplification. However, when only caspase 3
was inhibited, the initial suppression of DNA amplifica-
tion observed at 48 hpi was not apparent at 72 hpi. The
recovery of DNA amplification at 72 hpi was not concur-
rent with a recovery of infectious progeny production at
FIG. 6. Virus progeny production and TUNEL-positive cells from
ADV-infected cultures treated with the cathepsin B inhibitor, Ac-FA-
FMK. CrFK cells were pretreated with inhibitor for 24 h and infected
with 10 FFU/cell ADV under continuous treatment with the inhibitor. At
various times after infection, cells were harvested and titrated for virus
(A) or labeled with TUNEL and counted by flow cytometry (B). The
results from three separate cultures treated with Ac-FA-FMK are
shown.the same time (or up to 120 h). This indicated that ADV
was able to circumvent this block to its DNA replicationwhen the activity of only one caspase was prevented, but
did not circumvent the inhibition at the level of virus
progeny production. This suggests that caspase activity
may be involved in ADV replication at more than one
level.
We also examined the effect of caspase inhibition on
the expression of the ADV capsid proteins VP1 and VP2
as well as the major nonstructural protein, NS1. Levels of
VP1, VP2, and NS1 were greatly reduced in ADV-infected
CrFK cells treated with the broad-spectrum caspase in-
hibitor at 48 and 72 hpi (Fig. 8B). The increase in viral
protein expression at 48 hpi relative to 72 hpi following
treatment with the broad-spectrum caspase inhibitor
was variable as it was observed in two of four repeat
experiments. Virus protein expression was also mark-
edly reduced in caspase 3-inhibited cells at 48 hpi, but
not at 72 hpi. Inhibition of caspase 1 (Fig. 8B) or
caspases 6 and 8 (data not shown) had no effect. These
results are in agreement with the Southern analysis and
suggest that inhibition of specific caspases blocks viral
replication at an early stage, before substantial DNA
amplification and gene expression occur. However, in
the case of caspase 3 inhibition, ADV can circumvent the
early block in DNA amplification and gene expression.
FIG. 7. The effect of caspase inhibitors on MEV-induced apoptosis
and virus progeny production. (A) TUNEL-positive cells in MEV-infected
CrFK cells treated with caspase inhibitors (mean 6 SE for three
experiments). (B) MEV progeny production from CrFK cells that
were pretreated with inhibitor for 24 h, followed by infection with
MEV under continuous treatment with the inhibitor. Cells were har-
vested for virus titrations over 72 h of infection (mean 6 SE for three
experiments).
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In the current study, we have demonstrated an intri-
cate relationship between permissive ADV replication
and apoptosis. Apoptosis was induced in cells infected
with ADV as revealed by TUNEL labeling and Annexin
staining. Furthermore, the induction of apoptosis by ADV
required active viral replication because UV-inactivated
virus did not cause apoptosis. The activity of cellular
caspases, including caspase 3-like caspases, was es-
sential for ADV-induced apoptosis to proceed (Fig. 3).
Surprisingly, permissive replication of ADV was depen-
dent upon caspase activation (Fig. 5). Inhibition of
caspase activity during infection showed that the re-
quirement for caspase activation by ADV operated at an
early stage of ADV infection, before the bulk of virus DNA
amplification and gene expression occurred (Fig. 7).
In this study, we have strongly implicated caspases
and individual groups of caspases (i.e., caspase-3 like
caspases) as being important for the induction of apop-
tosis and permissive replication of ADV by means of
FIG. 8. Southern and Western blot analyses of ADV DNA amplifica-
tion and gene expression, respectively, following treatment with
caspase inhibitors over 72 h of infection. (A) Southern blot showing the
three major ADV DNA replicative intermediates, single-stranded virion
DNA (SS), duplex monomer DNA (DM), and duplex dimer DNA (DD).
The increased signal at 24 hpi in caspase 1 inhibitor-treated cells is not
representative and in three other experiments was equivalent to that of
untreated cells. (B) Western blot showing expression of the two ADV
capsid proteins, VP1 and VP2, and the main nonstructural protein, NS1,
detected by pooled mink anti-ADV antisera.specific caspase inhibitors. Although we could not dem-
onstrate specific activity of caspases by Western blot,several lines of evidence suggest that the inhibitors used
are targeting caspases in a specific manner. This in-
cludes the observation that caspase inhibitors had dif-
ferential effects on the reduction of apoptosis and the
replication of ADV compared to MEV. In addition, treat-
ment of ADV-infected cultures with the cathepsin B in-
hibitor Ac-FA-FMK, which can inhibit apoptosis following
TNFa treatment and activation of caspase 8 (Guicciardi
et al., 2000), had no effect on these measures. Further-
more, caspase 3 and caspase 8 were selectively inhib-
ited following treatment of ADV-infected cells with
caspase 3 or caspase 6–8 inhibitors as shown in
caspase-specific substrate cleavage assays (data not
shown), and preliminary experiments initiated in this
laboratory suggest that only specific caspases can inter-
act directly with ADV proteins (unpublished data).
Another mink parvovirus, MEV, did not require
caspase activity for permissive replication, although in-
fection with MEV did cause caspase-dependent apopto-
sis in vitro. Since we have examined these two viruses in
the same cell line, the dependence of ADV on caspase
activity must be virally encoded. The mechanism for this
remains unclear although several explanations may be
suggested. First, ADV replicates more slowly than MEV
both in vivo and in vitro (Storgaard et al., 1997; Uttenthal
et al., 1990). The slower transcription and replication
rates of ADV and the requirement for caspase activation
may reflect a general adaptation toward restricted repli-
cation in vivo. At a molecular level MEV mRNA tran-
scripts are produced more rapidly and attain higher lev-
els both in vivo and in CrFK cells, a finding that may
reflect the weakness of the ADV promoters (Storgaard et
al., 1997). Perhaps caspase activation functions either
directly or indirectly to compensate for defects in the
ADV RNA transcription program. Another potential expla-
nation may be related to differences in the capsid pro-
teins. The main capsid protein of MEV and other proto-
typical autonomous parvoviruses contains two distinct
domains not present in ADV: a trypsin-sensitive se-
quence (RXER) (Kariatsumari et al., 1991) and a viral
phospholipase A2 (PLA2; Za´dori et al., 2001). Both of
these motifs are important for early steps in parvovirus
replication, prior to DNA amplification (Paradiso et al.,
1984; Tullis et al., 1992; Za´dori et al., 2001), and their
deletion or mutation yields a virus that is impaired in its
ability to replicate and spread in culture, a situation similar
to that of ADV in CrFK cells. It is interesting to note that
intracellular Ca21-independent PLA2 contains a caspase
cleavage sequence and is a substrate for caspase 3 (Ma
and Turk, 2001), although no obvious caspase cleavage
site is present in the parvoviral (Ca21-binding) PLA2.
However, it is possible that ADV compensates for the
lack of these or similar motifs by interactions with
caspases (or other enzymes activated by caspases).A second difference between MEV- and ADV-induced
apoptosis was the requirement for caspase 6 and/or 8
231ADV REPLICATION DEPENDS ON CASPASE ACTIVITYactivity for maximal apoptosis to occur, with MEV-in-
duced apoptosis being dependent on the activity of
these caspases (Fig. 7A). To date, all previous studies
examining apoptosis induced by the autonomous parvo-
viruses have also indicated the importance of caspase 6
and 8 activity for maximum levels of cell death (Moffatt et
al., 1998; Rayet et al., 1998; Sol et al., 1999). Thus, it is
possible that the mechanisms of MEV- and ADV-induced
apoptosis are different, with MEV resembling other par-
voviruses such as MVM and H-1 more closely than ADV.
This raises the question of how ADV induces apoptosis
that does not appear to require the activity of the initiator
caspase 8. The redundancy of signaling pathways in-
volved in the activation of caspases may result in acti-
vation of enough initiator and executioner caspases that
caspase 8 is not required. However, if this were the case,
then MEV-induced apoptosis would also not require
caspase 8 activity. If the requirement for caspase 3-like
activity by ADV for efficient replication is so important
that it has been a positive selective factor in the evolution
of ADV, it is possible that ADV directly activates this
caspase following infection, as has been suggested for
Sindbis virus (Levine et al., 1993).
Although we have not yet formally implicated a spe-
cific ADV gene in the induction of apoptosis or as a target
for caspase activity, work from other parvovirus systems
suggests that the major nonstructural protein, NS1, is
likely to be involved. NS1 expression is a reliable indi-
cator of parvovirus replication as it is involved in viral
DNA replication and maturation, transcriptional regula-
tion, viral DNA packaging, and virion maturation
(Vanacker and Rommelaere, 1995). Transfection of the
NS1 gene can induce apoptosis, particularly in trans-
formed cell lines (Caillet-Fauquet et al., 1990; Moffatt et
al., 1998; Mousset et al., 1994). Although we were not
able to detect NS1 protein by IFA prior to the onset of
apoptosis, it may be that subdetectable levels are suffi-
cient to trigger the caspase cascade. This idea is sup-
ported by the observation that NS1 transcripts are
present in synchronized ADV-infected CrFK cells as early
as 3 h postrelease (Storgaard et al., 1997), before apop-
tosis is observed by Annexin-V staining or TUNEL.
The dependence of replication on caspase activity is
an unusual property among viruses and to date has been
described for only one other virus, hepatitis C virus. This
RNA virus utilizes caspase activity for the cleavage of its
nonstructural protein, NS5A (Satoh et al., 2000). One of
the cleaved NS5A forms is capable of translocating from
the cytoplasm of cells to the nucleus. This same NS5A
peptide also has potent transactivating function in the
presence of protein kinase A, suggesting that the
caspase-mediated cleavage events are important for vi-
ral replication at the level of transcriptional regulation of
host cell genes (Satoh et al., 2000). As NS1 of parvovi-
ruses shares a number of functions with NS5A including
the modulation of host cell genes (Moffatt et al., 1996;Vanacker and Rommelaere, 1995) and it is not yet known
how NS1 of ADV translocates to the nucleus, it is enticing
to propose that similar events may occur during ADV
infection, particularly if NS1 is the target for caspase
activity.
ADV is capable of inducing apoptosis in infected cells,
similar to other parvoviruses, and yet causes a persistent
infection in its adult host. This induction of apoptosis by
a persistently infecting virus is counterintuitive, particu-
larly because many persistently infecting viruses (e.g.,
Epstein–Barr virus, adenovirus, herpes simplex) (Chou
and Roizman, 1992; Han et al., 1996; Henderson et al.,
1993; Rao et al., 1997) encode genes that protect the host
cell from apoptosis. However, the absolute requirement
of specific caspase activation for permissive replication
of ADV may provide clues as to the mechanism of viral
persistence. Restricted replication of ADV in vivo occurs
in macrophages of lymph node tissue with no evidence
of lytic replication. It is possible that expression of bcl-2
or other inhibitors of apoptosis proteins (IAPs) (Green,
2000) in infected macrophages inhibits caspase activa-
tion and apoptosis and thus restricts ADV replication. If
apoptosis does not occur in response to ADV infection of
these cells, virus production might be severely restricted,
allowing initiation of a persistent infection. As a possible
parallel, Sindbis virus replicates permissively and
causes apoptosis in many vertebrate cells, but its infec-
tion in neurons is persistent. Stable transfection of the
anti-apoptotic bcl-2 oncogene into cells that normally
undergo apoptosis in response to Sindbis virus infection
blocks the apoptosis and establishes persistent virus
infection (Levine et al., 1993). Similar findings have also
been demonstrated for Semliki Forest (Scallan et al.,
1997), influenza (Olsen et al., 1996), and Japanese en-
cephalitis (Liao et al., 1998) viruses. The intimate rela-
tionship between ADV and the apoptosis machinery of
cells may have similarities to these other examples of
virus infection, and this may be an important determinant
of viral persistence, tissue specificity, and/or the different
pathogenicities observed between infection of adult
mink and that of mink kits.
Although programmed cell death has been demon-
strated during infection with many different viruses, the
finding that a DNA virus is dependent upon caspase
activation for DNA amplification and gene expression is
novel. Apoptosis of infected cells is generally thought of
as an innate host-cell response to limit virus production.
The importance of caspases in this antiviral response is
highlighted by the fact that some viruses encode pro-
teins that function to inhibit specific caspase activity
(e.g., poxviruses) (Everett and McFadden, 1999). More
specifically, caspases have recently been shown to have
potential roles in virus inactivation, by cleaving essential
structural proteins (Eleouet et al., 2000; Zhirnov et al.,
1999). It is perhaps not surprising then that some viruses
have evolved mechanisms to utilize host-cell apoptosis
232 BEST, WOLFINBARGER, AND BLOOMand, specifically, to utilize caspase activity to facilitate
permissive virus replication, including hepatitis C virus
(Satoh et al., 2000) and now ADV.
MATERIALS AND METHODS
Viruses and cell culture
A molecularly cloned stock of ADV-G was propagated
and assayed in CrFK cells as previously reported (Bloom
et al., 1990, 1993). For studies employing UV-inactivated
ADV, aliquots of virus stock were exposed to 9999 kJ UV
light in a Stratagene 2400 crosslinker, a treatment that
eliminated residual infectivity. The UV-inactivated virus
was used at the same dilution as the standard stock. The
MEV used in this study was MEV-2 Ithaca strain (Ut-
tenthal et al., 1990). CrFK cells were synchronized to G0
or to early S phase according to a previously developed
protocol (Oleksiewicz and Alexandersen, 1997).
Inhibition of caspase activation in virus-infected CrFK
cells
The inhibitors, their specificities, and the concentra-
tions used in these studies were as follows and are
listed in Table 1 (all purchased from Biomol, Plymouth
Meeting, PA, unless specified otherwise): Ac-YVAD-CHO
(caspase 1 inhibitor, 10 mM), Ac-DEVD-CHO (caspase 3
inhibitor, 10 mM), Ac-VEID-CHO (caspase 6 inhibitor, 10
mM), Ac-IETD-CHO (caspase 6 and 8 inhibitor, 10 mM),
z-VAD-FMK (broad-spectrum caspase inhibitor, 10 mM),
Int-H1-S6A (c-myc inhibitor, 1 mM), or Ac-FA-FMK (ca-
thepsin B inhibitor, 10 mM; Calbiochem, San Diego, CA).
Following synchronization to G0 phase, CrFK cells
were reseeded at 1 3 106 cells in 12.5-cm2 tissue culture
flasks, in Dulbecco’s minimal essential medium contain-
ing 10% fetal calf serum and the specified inhibitor(s).
After incubation for 24 h at 37°C the cultures were
infected with mock inoculum, ADV-G, or UV-inactivated
ADV-G at an m.o.i. of 10 FFU/cell and incubated for an
additional 72 h (and up to 120 h) at 31.8°C. MEV infec-
tions were done at 10 FFU/cell and incubated at 37°C.
Fresh medium containing new inhibitor was added to
infected cultures every 12–24 h.
Antibodies
Rabbit antibodies specific for ADV NS1 (1:10) had been
previously generated in this laboratory (Oleksiewicz et
al., 1998). A cocktail of murine monoclonal antibodies to
ADV capsid proteins was used (undiluted) to detect ADV
capsid proteins. Convalescent serum from MEV-chal-
lenged normal mink was used to detect MEV (graciously
provided by United Laboratories). The secondary anti-
bodies used were FITC-conjugated goat anti-rabbit IgG
(1:200; Roche), rhodamine-conjugated goat anti-mouse
IgG or anti-rabbit IgG (both used at 1:10; Roche), andCy-5 conjugated goat anti-mouse IgG (1:500 for confocal
microscopy; Amersham Pharmacia Biotech) or AMCA-
conjugated goat anti-mouse IgG (1:50 for epifluores-
cence, Accurate Chemical and Scientific Corp., West-
bury, NY). Protein A conjugated with Alexa Fluor 546
(Molecular Probes, Eugene, OR) was used to detect mink
IgG.
Immunofluorescence and TUNEL labeling
Cytospin preparations of virus-infected CrFK cells
were fixed in 3.7% formaldehyde and then either stained
for virus antigens or labeled with the TUNEL reaction
followed by staining for virus antigens. Antigens were
retrieved following formalin fixation by boiling slides in a
microwave using a commercial buffer (AR-10 solution;
BioGenex, San Ramon, CA). Cells were permeabilized in
0.1% sodium citrate, 0.1% Triton X-100 for 2 min at 4°C
and washed twice with phosphate-buffered saline (PBS).
Cytospins were FITC-TUNEL labeled using a commercial
kit (Roche). Sections were prepared and stained for
TUNEL from murine mammary gland or liver as positive
and negative controls, respectively. For staining viral
antigens, slides were blocked in PBS containing 1%
bovine serum albumin and 0.1% normal goat serum
(blocking solution) for 60 min at room temperature (RT).
Slides were washed briefly in PBS, and the primary
antibody diluted in blocking solution was added followed
by incubation for 60 min at RT. Controls of normal rabbit,
mouse, and/or mink serum in place of primary antibodies
were used. Slides were washed once in PBS containing
0.5% Tween 20 followed by three 5-min washes in PBS.
Cytospins were incubated with fluorescent secondary
detection reagents (antibodies or protein A) diluted in
blocking solution for 60 min at RT and washed as above.
The slides were mounted in Vectashield anti-fade mount-
ing medium (Vector Laboratories, Burlingame, CA) and
photographed using a Zeiss Axiovert inverted micro-
scope fitted with a Bio-Rad MRC 1000 laser confocal
module or a Nikon Microphot SA microscope fitted with
a Hamamatsu 5985 chilled digital camera.
Annexin-V staining
To detect early changes in phosphatidyl serine distri-
bution on the surface of apoptotic cells, cells were har-
vested by trypsinization, followed by washing and stain-
ing with Annexin-V/propidium iodide, according to the
manufacturer’s instructions (Calbiochem).
Flow cytometry
ADV-infected CrFK cells were washed in Dulbeco’s
PBS, trypsinized, and resuspended in PBS. The sus-
pended cells were fixed in 1% paraformaldehyde for 15
min on ice, washed twice in PBS, resuspended in etha-
nol, and placed on ice for 20 min. Finally, cells were
stained for apoptosis using the TUNEL reaction as spec-
233ADV REPLICATION DEPENDS ON CASPASE ACTIVITYified by the APO-direct kit (Pharmingen, San Diego, CA).
Cells were passed through a FACSCalibur flow cytome-
ter (Becton Dickinson), and 104 events from each sample
were analyzed using Cell Quest software.
Southern and Western blot analyses
Viral DNA amplification and protein expression were
visualized using Southern and Western blotting as pre-
viously described (Bloom et al., 1990; Fox and Bloom,
1999; Jensen et al., 2000). DNA from CrFK cell cultures
was extracted using a DNeasy tissue extraction kit (Qia-
gen, Valencia, CA). A pool of polyclonal mink anti-ADV
antisera was used for detection of viral proteins by West-
ern blot that strongly recognizes both structural and
nonstructural proteins (Bloom et al., 1983).
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